Exclusion Criteria:~1. COVID-19 positive test at the screening visit~2. Clinical, laboratory or neuro-imaging
findings consistent with:~ i. Other primary degenerative dementia, (dementia with Lewy bodies, frontotemporal
dementia, Huntington's disease, Creutzfeldt-Jakob Disease, Down's syndrome, etc.) ii. Other neurodegenerative
condition (Parkinson's disease, amyotrophic lateral sclerosis, etc.) iii. Cerebrovascular disease (major
infarct, one strategic or multiple lacunar infarcts, extensive white matter lesions > one quarter of the total
white matter) iv. Other central nervous system diseases (severe head trauma, tumors, subdural hematoma or other
space occupying processes, etc.) v. Seizure disorder vi. Other infectious, metabolic or systemic diseases
affecting central nervous system (syphilis, present hypothyroidism, present vitamin B12 or folate deficiency,
serum electrolytes out of normal range, juvenile onset diabetes mellitus, etc.)~3. Current presence of a
clinically significant major psychiatric disorder according to the criteria of the DSM-IV, or symptom that
could affect the subject's ability to complete the study~4. Current clinically significant systemic illness,
e.g., neoplasia, that is likely to result in deterioration of the subject's condition or affect the subject's
safety during the study~5. History of adrenal gland insufficiency~6. History of severe post-lumbar puncture
syndrome~7. Abnormalities in the blood clotting system or abnormal coagulation status~8. Women of childbearing
potential.~9. Male subjects with female partners of child-bearing potential who are unwilling or unable to
adhere to contraception requirements~10. Participation in another clinical study during the last 3 months~11.
Wheelchair-bound or bed-ridden~12. Any other criteria which in the opinion of the Investigator causes the
subject not to qualify for the study
